Van Berkom & Associates Inc. Sells 110,897 Shares of Stevanato Group S.p.A. $STVN

Van Berkom & Associates Inc. trimmed its position in Stevanato Group S.p.A. (NYSE:STVN) by 3.7% during the third quarter, HoldingsChannel.com reports. The fund owned 2,858,323 shares of the company’s stock after selling 110,897 shares during the quarter. Stevanato Group makes up 2.1% of Van Berkom & Associates Inc.’s portfolio, making the stock its 27th biggest position. Van Berkom & Associates Inc.’s holdings in Stevanato Group were worth $59,968,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also added to or reduced their stakes in the company. Wellington Management Group LLP acquired a new position in Stevanato Group during the second quarter valued at approximately $22,621,000. Ranger Investment Management L.P. bought a new stake in Stevanato Group during the second quarter worth $21,438,000. Cooper Investors PTY Ltd. lifted its stake in Stevanato Group by 4.4% during the second quarter. Cooper Investors PTY Ltd. now owns 668,494 shares of the company’s stock worth $12,080,000 after purchasing an additional 28,265 shares during the last quarter. Schwartz Investment Counsel Inc. boosted its holdings in shares of Stevanato Group by 15.0% in the 3rd quarter. Schwartz Investment Counsel Inc. now owns 661,136 shares of the company’s stock valued at $13,871,000 after purchasing an additional 86,385 shares in the last quarter. Finally, Fenimore Asset Management Inc acquired a new stake in shares of Stevanato Group in the 3rd quarter valued at $12,212,000.

Stevanato Group Trading Down 0.4%

Shares of Stevanato Group stock opened at €13.68 on Tuesday. The firm’s 50 day moving average is €19.65 and its 200 day moving average is €17.98. The firm has a market capitalization of $4.14 billion, a PE ratio of 23.58, a price-to-earnings-growth ratio of 1.15 and a beta of 0.80. Stevanato Group S.p.A. has a 1 year low of €12.05 and a 1 year high of €25.45. The company has a current ratio of 1.73, a quick ratio of 1.08 and a debt-to-equity ratio of 0.22.

Stevanato Group (NYSE:STVN) last issued its quarterly earnings data on Tuesday, November 3rd. The company reported €0.16 EPS for the quarter, missing the consensus estimate of €0.17 by (€0.01). The company had revenue of €326.06 million during the quarter. Stevanato Group had a net margin of 11.24% and a return on equity of 10.51%. Equities research analysts forecast that Stevanato Group S.p.A. will post 0.67 earnings per share for the current fiscal year.

Insider Buying and Selling at Stevanato Group

In other Stevanato Group news, insider Mauro Stocchi sold 13,649 shares of the business’s stock in a transaction on Monday, September 28th. The shares were sold at an average price of €21.50, for a total transaction of €293,453.50. Following the sale, the insider owned 400,000 shares of the company’s stock, valued at approximately €8,600,000. The trade was a 3.30% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on STVN. William Blair lowered Stevanato Group from an “outperform” rating to a “market perform” rating in a research note on Wednesday, November 4th. Citigroup lowered their price target on Stevanato Group from $26.00 to $20.00 and set a “buy” rating for the company in a report on Wednesday, November 4th. UBS Group dropped their price objective on Stevanato Group from $23.00 to $16.00 and set a “neutral” rating for the company in a research report on Wednesday, November 4th. Weiss Ratings raised Stevanato Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, August 27th. Finally, Deutsche Bank Aktiengesellschaft initiated coverage on Stevanato Group in a research note on Wednesday, October 7th. They issued a “hold” rating on the stock. Two equities research analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, Stevanato Group presently has a consensus rating of “Moderate Buy”.

Stevanato Group Company Profile

Stevanato Group is an Italian provider of drug-containment and drug-delivery solutions for the pharmaceutical, biotechnology and diagnostic industries. Founded in 1949 by Giovanni Stevanato, the company began as a glassmaking business and has expanded into a global supplier of products and services for the life sciences sector.

The company makes primary packaging for injectable medicines, including glass vials, cartridges, syringes and ampoules. Its offerings also include ready-to-use containers, as well as services such as product development, analytical testing and packaging support.

Stevanato Group also designs and manufactures equipment and technologies used to produce, inspect and package pharmaceutical containers and delivery systems.